(Q68411815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Quantifying the carcinogenicity of antineoplastic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

3 January 2023

author name string

J. M. Kaldor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383970

3 January 2023

N. E. Day

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383970

3 January 2023

K. Hemminki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383970

3 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3383970

3 January 2023

publication date

1 April 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

24 September 2019

https://api.elsevier.com/content/article/PII:0277537988903021?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

https://api.elsevier.com/content/article/PII:0277537988903021?httpAccept=text/plain

3 January 2023

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

European Journal of Cancer & Clinical Oncology

3 January 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

703-711

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

Risk of new cancers in patients with Hodgkin's disease

24 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease

3 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma

3 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

3 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

3 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Melphalan may be a more potent leukemogen than cyclophosphamide

3 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Acute leukemia after chemotherapy (melphalan)

3 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

3 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults

3 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

3 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide

3 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Acute leukaemia after busulphan

3 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)

3 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

3 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

3 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

3 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

A carcinogenic potency database of the standardized results of animal bioassays

3 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data

3 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Life-span carcinogenicity tests with 4-amino-N10-methylpteroylglutamic acid (methotrexate) in Swiss mice and Syrian golden hamsters

3 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents

3 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Some tautologous aspects of the comparison of carcinogenic potency in rats and mice

3 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Interspecies comparison of carcinogenic potency

3 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

3 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0277-5379(88)90302-1

3 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3383970%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference